LIMBER UniLeg: Rapid, On-demand, and Scaled-up Manufacturing of Customized Transtibial Prosthetic Legs for Amputees
Launched by LIMBER PROSTHETICS & ORTHOTICS INC · Oct 17, 2024
Trial Information
Current as of June 28, 2025
Recruiting
Keywords
ClinConnect Summary
The LIMBER UniLeg trial is studying a new type of prosthetic leg designed for people who have lost a leg below the knee. This prosthetic is made using 3D printing, which means it can be produced faster and at a lower cost compared to traditional prosthetics. The goal of the trial is to see if the LIMBER UniLeg works as well as regular prosthetic legs that don’t have motors or sensors. Participants will use their usual prosthetic for one month and then switch to the LIMBER UniLeg for another month to compare their experiences.
To join the study, participants need to be between 18 and 75 years old, have been living with a below-knee amputation for at least a year, and currently use a passive (non-motorized) prosthetic. They should be in good health and able to walk at least a mile a day. This trial is taking place in the Southern California area, and participants will need to commit to following specific guidelines about their activity and diet during the study. Overall, this research aims to improve access to prosthetic limbs for amputees around the world.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Provision of signed and dated informed consent form.
- • 2. Stated willingness to comply with all study procedures and availability for the duration of the study.
- • 3. Persons, aged 18 to 75
- • 4. In good general health as determined by clinical site monitor
- • 5. Weight \< 125kg
- • 6. Are not diabetic (self reported)
- • 7. Be a unilateral transtibial amputee of more than 1 year since amputation
- • 8. Have an existing prosthetic device(s) that does not use sensors or motors (is passive)
- • 9. Live in the Southern California region (within 50 miles of UCSD)
- • 10. Has sufficient sensation in residual limb as tested by the clinical site monitor
- • 11. Agreement to adhere to Lifestyle Considerations throughout study duration 11a. Use the testing device (EPD or UniLeg) only during the testing periods. 11b. Walk at least 14,000 steps per week (average of 1 mile per day). 11c. Maintain a similar diet and activity level throughout study duration (no abrupt changes of weight, activity, etc.)
- Exclusion Criteria:
- • 1. Not currently using a prosthetic device
- • 2. Prosthetic device with active motors, sensors, etc.
- • 3. Pregnancy (due to fall risk)
- • 4. Diabetic (due to poor limb sensation), self reported
- • 5. No under 18 (due to inability to consent)
- • 6. No over 75 (due to fall risk)
- • 7. Poor proprioception or sensation at the residual limb
About Limber Prosthetics & Orthotics Inc
Limber Prosthetics & Orthotics Inc. is a leading innovator in the field of rehabilitation technology, specializing in the design, development, and manufacturing of advanced prosthetic and orthotic solutions. With a commitment to enhancing patient mobility and quality of life, Limber employs cutting-edge research and clinical trials to evaluate the efficacy and safety of its products. The company collaborates with healthcare professionals to ensure that its offerings meet the highest standards of functionality and comfort, ultimately aiming to empower individuals with mobility challenges to lead more active and fulfilling lives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
La Jolla, California, United States
San Diego, California, United States
Patients applied
Trial Officials
Herb Barrack, CPO
Principal Investigator
LIMBER Prosthetics & Orthotics Inc
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported